RiVax®
Paper
A lyophilized formulation of RiVax, a recombinant ricin subunit vaccine, retains immunogenicity
Smallshaw, J.E. and E.S. Vitetta, A lyophilized formulation of RiVax, a recombinant ricin subunit vaccine, retains immunogenicity. Vaccine, 2010. 28(12): p. 2428-35.
Paper
Cytokine-secreting follicular T cells shape the antibody repertoire
Reinhardt, R.L., H.E. Liang, and R.M. Locksley, Cytokine-secreting follicular T cells shape the antibody repertoire. Nat Immunol, 2009. 10(4): p. 385-93.
Paper
A new model of bioterrorism risk assessment
Radosavljevic, V. and G. Belojevic, A new model of bioterrorism risk assessment. Biosecur Bioterror, 2009. 7(4): p. 443-51.
Paper
Progressive circumscribed sclerosis–a novel side-effect of immunotherapy with aluminium-adsorbed allergen extracts
El, S.-C., et al., Progressive circumscribed sclerosis--a novel side-effect of immunotherapy with aluminium-adsorbed allergen extracts. Allergy, 2009. 64(6): p. 965-7.
Paper
Post-exposure targeting of specific epitopes on ricin toxin abrogates toxin- induced hypoglycemia, hepatic injury, and lethality in a mouse model
Roche, J.K., et al., Post-exposure targeting of specific epitopes on ricin toxin abrogates toxin- induced hypoglycemia, hepatic injury, and lethality in a mouse model. Lab Invest, 2008. 88(11): p. 1178-91.
Paper
Structure-based antigen design: a strategy for next generation vaccines
Dormitzer, P.R., J.B. Ulmer, and R. Rappuoli, Structure-based antigen design: a strategy for next generation vaccines. Trends Biotechnol, 2008. 26(12): p. 659-67.
Paper
Ricin: A type II ribosome inactivating protein, in Vaccines for Biodefense and Neglected Diseases
Brey, R.N. and N.J. Mantis, Ricin: A type II ribosome inactivating protein, in Vaccines for Biodefense and Neglected Diseases, A. Barrett, Editor. 2008, Elsevier. p. 1100-1115.
Paper
RiVax, a recombinant ricin subunit vaccine, protects mice against ricin delivered by gavage or aerosol
Smallshaw, J.E., J.A. Richardson, and E.S. Vitetta, RiVax, a recombinant ricin subunit vaccine, protects mice against ricin delivered by gavage or aerosol. Vaccine, 2007. 25(42): p. 7459-69.
Paper
Novel chimeric anti-ricin antibody C4C13 with neutralizing activity against ricin toxicity
Wang, Y., et al., Novel chimeric anti-ricin antibody C4C13 with neutralizing activity against ricin toxicity. Biotechnol Lett, 2007. 29(12): p. 1811-6.
Paper
A Rapid, Three-Step Process for the Preformulation of aRecombinant Ricin Toxin A-Chain Vaccine
Peek, L.J., R.N. Brey, and C.R. Middaugh, A rapid, three-step process for the preformulation of a recombinant ricin toxin A-chain vaccine. J Pharm Sci, 2007. 96(1): p. 44-60.